Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elevation Oncology Inc.

    NASDAQ: ELEV · Real-Time Price · USD
    0.38
    0.06 (18.79%)
    At close: Jun 09, 2025, 3:59 PM

    Elevation Oncology Statistics

    Share Statistics

    Elevation Oncology has 59.22M shares outstanding. The number of shares has increased by 8.2% in one year.

    Shares Outstanding

    n/a
    		 59.22M

    Shares Change (YoY)

    n/a
    		 8.2%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 67.63%

    Shares Floating

    n/a
    		 53M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,228

    FTD / Avg. Volume

    n/a
    		 0.25%

    Short Selling Information

    The latest short interest is 4.43M, so 7.47% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.43M

    Short % of Shares Out

    n/a
    		 7.47%

    Short % of Float

    n/a
    		 9.14%

    Short Ratio (days to cover)

    n/a
    		 5.66

    Valuation Ratios

    The PE ratio is -0.72 and the forward PE ratio is -0.73. Elevation Oncology's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.72

    Forward PE

    n/a
    		 -0.73

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.54

    P/FCF Ratio

    n/a
    		 -0.89

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Elevation Oncology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 21.21, with a Debt / Equity ratio of 0.52.

    Current Ratio

    n/a
    		 21.21

    Quick Ratio

    n/a
    		 21.21

    Debt / Equity

    n/a
    		 0.52

    Debt / EBITDA

    n/a
    		 -0.7

    Debt / FCF

    n/a
    		 -0.86

    Interest Coverage

    n/a
    		 -37.16

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,308,382.35

    Employee Count

    n/a
    		 34

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 43K

    Effective Tax Rate

    n/a
    		 -0.1%

    Stock Price Statistics

    The stock price has increased by -90.93% in the last 52 weeks. The beta is 1.45, so Elevation Oncology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.45

    52-Week Price Change

    n/a
    		 -90.93%

    50-Day Moving Average

    n/a
    		 0.32

    200-Day Moving Average

    n/a
    		 0.53

    Relative Strength Index (RSI)

    n/a
    		 49.4

    Average Volume (20 Days)

    n/a
    		 1,316,584

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -44.7M

    Net Income

    n/a
    		 -44.48M

    EBITDA

    n/a
    		 -44.7M

    EBIT

    n/a
    		 -43.24M

    Earnings Per Share (EPS)

    n/a
    		 -0.78
    Full Income Statement

    Balance Sheet

    The company has 49.46M in cash and 31.13M in debt, giving a net cash position of 18.33M.

    Cash & Cash Equivalents

    n/a
    		 49.46M

    Total Debt

    n/a
    		 31.13M

    Net Cash

    n/a
    		 18.33M

    Retained Earnings

    n/a
    		 -240.46M

    Total Assets

    n/a
    		 82.22M

    Working Capital

    n/a
    		 77.96M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -36.36M and capital expenditures 0, giving a free cash flow of -36.36M.

    Operating Cash Flow

    n/a
    		 -36.36M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -36.36M

    FCF Per Share

    n/a
    		 -0.63
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ELEV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ELEV is $3, which is 837.5% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 837.5%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.82

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist